New York, NY (October 7, 2014) – The Diabetes Research Institute Foundation is pleased to announce that Marc S. Goldfarb of Short Hills, NJ, has been elected to serve on its National Board of Directors. He also serves as co-chairman of the organization’s Northeast Region Board, alongside Bruce A. Siegel. Goldfarb was also appointed to serve as Chairman of the Audit Committee of the National Board.
“I am committed to this organization on a deep and personal level. I believe the Diabetes Research Institute will ultimately provide a biological cure for the millions living with type 1 diabetes,” said Goldfarb, who has a daughter with type 1. “Getting the scientists the funds they need to continue this cure-focused research is of the utmost importance.”
Goldfarb recently served as Senior Vice President, General Counsel and Corporate Secretary to Kid Brands, Inc. (f/k/a Russ Berrie & Company), a NYSE-listed manufacturer of infant and juvenile products and is currently serving as Counsel to Lowenstein Sandler LLP. Prior to Kid Brands, he was: Vice President, General Counsel and Corporate Secretary of Journal Register Company, a NYSE-listed newspaper publishing company: Managing Director and General Counsel of The Vertical Group, an international private equity firm; and a partner with a New York City law firm. A graduate of Cornell University, Goldfarb also received a J.D. degree from the University of Pennsylvania Law School.
Goldfarb has served on the DRIF’s Northeast Region Board of Directors since 2006 and as a member of its Executive Committee since 2012. He has also served as co-chair and/or a member of the event committee for the organization’s Carnival for a Cure event since 2006 and as Co-Chair for the 2008 Northeast Research Update.
“I am very pleased to have Marc Goldfarb take on an even greater role in our efforts. The Northeast Region continues to grow under his co-leadership, and I believe that reach will only accelerate from here,” said Harold G. Doran, Jr., National Board chairman. “I’m confident that the skills he brings to the table, coupled with his dedication to finding a cure, will be of great benefit.”
The national office of the Diabetes Research Institute Foundation is located at 200 South Park Road, Suite 100, Hollywood, FL, 33021. Two regional offices operate as part of the organization’s Northeast Region. The Jericho office, located at 410 Jericho Turnpike, Suite 201, Jericho, NY, 11753, can be reached at 516.822.1700. To contact the Manhattan office, located at 381 Park Avenue, South, Suite 1118, New York, NY, 10016, call 212.888.2217.
About the Diabetes Institute and Foundation
The Diabetes Research Institute Foundation is the organization of choice for those who are serious, passionate and committed to curing diabetes. Its mission – to provide the Diabetes Research Institute with the funding necessary to cure diabetes now – is a testament to the belief that tomorrow is not soon enough to cure those living with diabetes.
The Diabetes Research Institute at the University of Miami Miller School of Medicine leads the world in cure-focused research. As the largest and most comprehensive research center dedicated to curing diabetes, the DRI is aggressively working to develop a biological cure by restoring natural insulin production and normalizing blood sugar levels without imposing other risks. Researchers have already shown that diabetes can be reversed through islet transplantation, with some study patients living without the need for insulin injections for more than a decade. The Institute is now building upon these promising outcomes by developing the DRI BioHub, an integrated “mini organ” that mimics the native pancreas, containing thousands of insulin-producing cells that sense blood sugar levels and produce the precise amount of insulin needed in real time. The Diabetes Research Institute and Foundation were created for one reason – to cure diabetes – which is and will continue to be its singular focus until that goal is reached. For the millions of children and adults affected by diabetes, the Diabetes Research Institute is the best hope for a cure.
For more information, contact 1-800-321-3437, info@drif.org or visit DiabetesResearch.org.
# # #
Media Contact:
Lauren Schreier
lschreier@drif.org